Cancer Center Amsterdam
-
Immune-modulating effects on tumor-draining lymph nodes of neoadjuvant chemoradiotherapy combined with dual immunotherapy in patients with T3-4N0-2 NSCLC
Ulas, E. B., Koomen, S. J. I., Vrijmoet, A., Houda, I., Korkmaz, H. I., Dickhoff, C., Bahce, I., Senan, S., de Gruijl, T. D., Fransen, M. F., Radonic, T., van Maldegem, F. & Schneiders, F. L., 28 Nov 2025, In: Journal for Immunotherapy of Cancer. 13, 11, e013237.Research output: Contribution to journal › Article › Academic › peer-review
-
Survival outcomes with carboplatin versus cisplatin and the impact of COVID-19 on platinum choice: A nationwide Netherlands registry study in small cell lung cancer patients (CACIS)
Houda, I., Naves, D., Ulas, E. B., Lissenberg-Witte, B. I., Barlo, N. P., Kastelijn, E. A., Bouhaddou, H., Shaikh, R., Dickhoff, C., Radonic, T., Schneiders, F. L., Senan, S., Damhuis, R. A. M. & Bahce, I., 17 Nov 2025, In: Eur. J. Cancer. 230, 116042.Research output: Contribution to journal › Article › Academic › peer-review
-
Baseline expression levels of drug metabolizing enzymes in non-small cell lung cancer biopsies show promising biomarker and target potential for long-term response to pembrolizumab
de Ridder, K., Vinchesi Chiara, M., Giron, P., Sohrab, N., Cuppens, K., Korkmaz, E., Ulas, E. B., Bahce, I., Descoster, L. & Goyvaerts, C., 13 Nov 2025, In: medRxiv.Research output: Contribution to journal › Article › Academic
- All publications